Save these records after each Target order: Itemized receipt: It should list each product, not just the total charge
The powder form is less susceptible to temperature fluctuations that can cause degradation in liquid formulations
Zepbound (tirzepatide for weight management) Zepbound received FDA approval in November 2023 for chronic weight management in adults with a BMI of 30 or greater, or a BMI of 27 or greater with at least one weight-related condition
At these doses, you should be working closely with your provider and monitoring for side effects
Safety Considerations and Provider Guidance for Medicaid-Covered GLP-1 Therapy GLP-1 medications carry important safety considerations that Medicaid programs evaluate during coverage review
Common side effects may include gastrointestinal symptoms such as nausea, vomiting, or diarrhea, which often diminish over time